Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Watchful waiting versus immediate repair for a hidden hernia on the other side of the groin

Official title: WATCH IT TRIAL WAtchful Waiting Versus immediaTe Repair for Occult Contralateral Hernias Found During MIS Inguinal Hernia Repair Trial.

Run by Northwestern University · NCT07461558 · Data updated 2026-11-12

This trial will test whether fixing a small, hidden hernia found on the opposite side during minimally invasive groin hernia surgery or leaving it alone is better for adults having unilateral symptomatic inguinal hernia repair.

More Inguinal Hernia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment152 (estimated)
SponsorNorthwestern University
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedApril 1, 2026
Main results expectedApril 2028
Study endsApril 2029
Registry record updatedNovember 6, 2026
Trial IDNCT07461558 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older having minimally invasive surgery for a symptomatic unilateral inguinal hernia who are found during the operation to have an occult contralateral inguinal hernia and can provide informed consent.

Probably not a fit

Patients with symptomatic bilateral hernias on exam, prior contralateral hernia repair, urgent presentations, contraindications to anesthesia or surgery, pregnant patients, or those unable or unwilling to consent are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, non-inferiority trial comparing immediate repair to watchful waiting when an occult contralateral inguinal hernia is discovered during minimally invasive unilateral hernia repair. Patients are randomized intraoperatively and followed at 30 days, 1 year, and 2 years to compare recovery, quality of life, and the need for later surgery. The primary short-term outcome is 30-day quality of life, and the watchful waiting arm will capture any hernia-related complications or subsequent repairs. The trial is led by Northwestern with procedures performed at participating surgical centers.

Why it matters

Potential benefit: If successful, the trial could reduce unnecessary immediate repairs and lower the risk of additional surgery or long-term groin pain by supporting a safe watchful waiting approach, or alternatively justify immediate repair to prevent future operations.

How similar studies have gone: There is no level 1 randomized evidence on this question; observational series and surgeon opinion are mixed with some data suggesting immediate repair prevents reoperation but concerns remain about repair-related chronic pain.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female patients ≥18 years old
* Symptomatic unilateral inguinal hernia
* Occult contralateral hernia identified intraoperatively
* Ability to provide informed consent

Exclusion Criteria:

* Prior contralateral inguinal hernia repair
* Symptomatic, bilateral inguinal hernias confirmed on physical exam
* Contraindications to general anesthesia or surgery
* Urgent or emergent presentations
* Adults unable to consent
* Pregnant patients

Where it's running

  • Northwestern Memorial Hospital
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.